Wir sind mit live! Mehr erfahren
A-Symbol

Agilent Technologies

172,97 USD
-2,58
1,47 %
Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT
Vor Börsenbeginn
Nachbörslich
172,97
0,00
0 %
1 Tag
-1,47 %
5 Tage
0,91 %
1 Monat
12,54 %
3 Monate
27,09 %
6 Monate
46,27 %
Seit Jahresbeginn
25,39 %
1 Jahr
22,59 %
5 Jahre
11,75 %
10 Jahre
283,1 %
 

Profil: Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Mitarbeiter: 18.200

Nachrichten

Positiv
Neutral
Negativ
Stimmung 3 Monate
Positiv 42,9 %
Neutral 57,1 %
Negativ 0 %
Neutral
Business Wire
vor 3 Tagen
Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
SANTA CLARA, Calif. & PHILADELPHIA--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash transaction valued at $240 million in cash at closing and up to an additional $30 million based on achieving future performance milestones. Proscia is a leading independent provider of enterprise digital pathology software, serving.
Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
Positiv
Zacks Investment Research
vor 4 Tagen
Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?
Here is how Agilent Technologies (A) and Concentra Group (CON) have performed compared to their sector so far this year.
Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?
Neutral
Seeking Alpha
vor 14 Tagen
Dividend Champion, Contender, And Challenger Highlights: Week October 4
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Dividend Champion, Contender, And Challenger Highlights: Week October 4
Neutral
Business Wire
vor 15 Tagen
Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time.
Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows
Neutral
Business Wire
vor 17 Tagen
Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis. Developed for use with compatible Agilent BioTek automated imaging systems, the module uses AI-based segmentation without requiring conventional threshold setting or parameter tuning. By incorporating the.
Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers
Positiv
Zacks Investment Research
vor 21 Tagen
Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue?
Agilent (A) reported earnings 30 days ago. What's next for the stock?
Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue?
Neutral
Seeking Alpha
vor 23 Tagen
Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript
Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript
Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript
Positiv
MarketBeat
vor 23 Tagen
Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation
Agilent Technologies NYSE: A executives outlined continued growth momentum, driven by improving end markets, market-share gains, instrument replacement cycles and operational changes under the company's Ignite transformation program, during a J.P. Morgan conference discussion.
Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation
Neutral
Seeking Alpha
vor 25 Tagen
Lithium Miners News For The Month Of September 2026
China's lithium carbonate spot prices and spodumene spot prices were significantly lower the past month. Lithium market news - China's biggest lithium mine (CATL's Jianxiawo Mine) loses its license and is back on care and maintenance. Why has Benchmark flipped 2027 lithium from Surplus to Deficit? Lithium miner news - Ganfeng Lithium swings to profit in H1 2026 as revenue nearly triples. Tianqi Lithium's profit surges 49-fold in H1 as revenue soars 153%.
Lithium Miners News For The Month Of September 2026
Neutral
Business Wire
vor 25 Tagen
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStationDx software, extending the company's automated electrophoresis portfolio into regulated clinical laboratory environments. The new CE-IVD-labeled systems and software are designed to support standardized and traceable quality control of DNA and RNA samples used in clinical next-generation sequencing.
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control
Kursdiagramme mit Lightweight Charts™ umgesetzt